A clinical study to find out the effect of Anjana as Dinacharya in Myopia patients.
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: H521- Myopia
- Registration Number
- CTRI/2023/02/050101
- Lead Sponsor
- Dr Akshaya Mohandas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with diminished visual acuity between the age 15 to 35
Exclusion Criteria
Anjana Anarha
Patients with history of ocular trauma and surgery
Patients with other ocular pathologies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effect of Pipplyadi Varti Anjana on myopia progression in children?
How does Pipplyadi Varti Anjana compare to orthokeratology in slowing axial elongation in myopic patients?
Are there specific ocular biomarkers that correlate with response to Pipplyadi Varti Anjana treatment in myopia?
What are the potential adverse events associated with long-term use of Pipplyadi Varti Anjana in myopia management?
What combination therapies with Pipplyadi Varti Anjana show promise in treating high myopia compared to monotherapy?